KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

Market Cap	138.73B -18.6%
Revenue (ttm)	90.11B +12.9%
Net Income	174.16M -94.2%
EPS	15.95 -94.4%
Shares Out	10.91M
PE Ratio	796.61
Forward PE	n/a
Dividend	50.00 (0.42%)
Ex-Dividend Date	Dec 29, 2025

Volume	20,188
Average Volume	61,264
Open	12,730
Previous Close	12,720
Day's Range	12,670 - 12,850
52-Week Range	11,710 - 18,710
Beta	0.80
RSI	51.86
Earnings Date	n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 032300

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.